JMIR Medical Informatics

Atrial fibrillation (AF) is a progressive disease, and its clinical type is classified according to the AF duration: paroxysmal AF, persistent AF (PeAF; AF duration of less than 1 year), and long-standing persistent AF (AF duration of more than 1 year). When considering the indication for catheter ablation, having a long AF duration is considered a risk factor for recurrence, and therefore, the duration of AF is an important factor in determining the treatment strategy for PeAF.

Mild cognitive impairment (MCI) poses significant challenges in early diagnosis and timely intervention. Underdiagnosis, coupled with the economic and social burden of dementia, necessitates more precise detection methods. Machine learning (ML) algorithms show promise in managing complex data for MCI and dementia prediction.

Clinical named entity recognition (CNER) is a fundamental task in natural language processing used to extract named entities from electronic medical record texts. In recent years, with the continuous development of machine learning, deep learning models have replaced traditional machine learning and template-based methods, becoming widely applied in the CNER field. However, due to the complexity of clinical texts, the diversity and large quantity of named entity types, and the unclear boundaries between different entities, existing advanced methods rely to some extent on annotated databases and the scale of embedded dictionaries.

The integration of information systems in healthcare and social welfare organizations has brought significant changes in patient and client care. This integration is expected to offer numerous benefits, but simultaneously the implementation of health information systems and client information systems can also introduce added stress due to the increased time and effort required by professionals.

Social networking services (SNS) closely reflect the lives of individuals in modern society and generate large amounts of data. Previous studies have extracted drug information using relevant SNS data. In particular, it is important to detect adverse drug reactions (ADRs) early using drug surveillance systems. To this end, various deep learning methods have been employed, which have studied multiple languages in addition to English.

Low back pain (LBP) presents with diverse manifestations, necessitating personalized treatment approaches that recognize various phenotypes within the same diagnosis, which could be achieved through precision medicine. Although prediction strategies have been explored, including those employing artificial intelligence (AI), they still lack scalability and real-time capabilities. Digital care programs (DCPs) facilitate seamless data collection through the Internet of Things and cloud storage, creating an ideal environment for developing and implementing an AI predictive tool to assist clinicians in dynamically optimizing treatment.

Prostate cancer is the second leading cause of death among American men. If detected and treated at an early stage, prostate cancer is often curable. However, an advanced stage such as metastatic castration-resistant prostate cancer (mCRPC) has a high risk of mortality. Multiple treatment options exist, the most common included docetaxel, abiraterone, and enzalutamide. Docetaxel is a cytotoxic chemotherapy, whereas abiraterone and enzalutamide are androgen receptor pathway inhibitors (ARPI). ARPIs are preferred over docetaxel due to lower toxicity. No study has used machine learning with patients’ demographics, test results, and comorbidities to identify heterogeneous treatment rules that might improve the survival duration of patients with mCRPC.

In the rapidly advancing landscape of artificial intelligence (AI) within integrative health care (IHC), the issue of data ownership has become pivotal. This study explores the intricate dynamics of data ownership in the context of IHC and the AI era, presenting the novel Collaborative Healthcare Data Ownership (CHDO) framework. The analysis delves into the multifaceted nature of data ownership, involving patients, providers, researchers, and AI developers, and addresses challenges such as ambiguous consent, attribution of insights, and international inconsistencies. Examining various ownership models, including privatization and communization postulates, as well as distributed access control, data trusts, and blockchain technology, the study assesses their potential and limitations. The proposed CHDO framework emphasizes shared ownership, defined access and control, and transparent governance, providing a promising avenue for responsible and collaborative AI integration in IHC. This comprehensive analysis offers valuable insights into the complex landscape of data ownership in IHC and the AI era, potentially paving the way for ethical and sustainable advancements in data-driven health care.

Transformer-based language models have shown great potential to revolutionize health care by advancing clinical decision support, patient interaction, and disease prediction. However, despite their rapid development, the implementation of transformer-based language models in health care settings remains limited. This is partly due to the lack of a comprehensive review, which hinders a systematic understanding of their applications and limitations. Without clear guidelines and consolidated information, both researchers and physicians face difficulties in using these models effectively, resulting in inefficient research efforts and slow integration into clinical workflows.

Artificial intelligence (AI) has shown great promise in assisting medical diagnosis, but its application in renal pathology remains limited.

Interoperability has been designed to improve the quality and efficiency of healthcare. Interoperability allows the Centers for Medicare and Medicaid Services to collect data on quality measures as part of meaningful use. Covered providers who fail to provide data have lower rates of reimbursement. Unintended consequences arise in each step of this process. Providers are not reimbursed for the extra time required to generate data. Patients don’t have control over when and how their data are provided to or used by the government. Large datasets increase the chances of an accidental data breach or intentional hacker attack. After detailing the issues, we describe several solutions, including an Appropriate Data Use Review Board. It is designed to oversee certain aspects of the process and ensure accountability and transparency.

Data from multiple organizations are crucial for advancing learning health systems. However, ethical, legal, and social concerns may restrict the use of standard statistical methods that rely on pooling data. Although distributed algorithms offer alternatives, they may not always be suitable for health frameworks.